EUVIMEDEUVIMED entdecken
Crossref

Sustained Delivery of Exosome‐Encapsulated Ellagic Acid via Injectable Self‐Healing Hydrogel for Spinal Cord Injury Repair

Xiaoling Zhou, Yan Lin, Rongqiu Wang, Yanling Wu, Xingyue Zhong, Jili Wu, Zaiyi Luo, Fei Lei iD, Xingyuan Liu, Xiyao Li, Xueyun Xu, Yanqi Li und 7 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiaoling Zhou und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Ellagic Acid, Exosomes, Hydrogels. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Sichuan Science and Technology Program, Science and Technology Strategic Cooperation Program of Luzhou Municipal People's Government and Southwest Medical University, Open Projects Fund of the Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following primary mechanical trauma, spinal cord injury evolves through a complex secondary cascade involving blood–spinal cord barrier disruption, ischemia‐reperfusion injury, oxidative stress, and neuroinflammation, which collectively propagate neuronal death, demyelination, and glial scarring to preclude functional recovery. Current treatments mitigate single processes but not all at once, limiting their efficacy. To develop an effective multivalent treatment, the small molecule ellagic acid, which inhibits inflammation and oxidative damage while protecting the barrier between blood and spinal cord, was encapsulated within exosomes derived from bone marrow mesenchymal stem cells. These exosomes, by themselves, have been shown to promote neural repair, and loading ellagic acid into them stabilized the drug and increased its bioavailability. The ellagic acid‐loaded exosomes (Exos‐EA) were formulated into a self‐healing chitosan/hyaluronic acid hydrogel (Exos‐EA@CS/HA‐Gel) to prolong their retention and release at the injection site. The resulting Exos‐EA@CS/HA‐Gel inhibited lipopolysaccharide‐induced inflammatory responses in murine microglial cultures and protected human neuroblastoma cell lines from death due to oxidative stress. In a rat model of spinal cord injury, Exos‐EA@CS/HA‐Gel restored the function of the barrier between blood and spinal cord, promoting tissue repair. These results suggest that Exos‐EA@CS/HA‐Gel may be effective against spinal cord injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesEllagic AcidExosomesHydrogelsAnimalsHumansRatsMiceHyaluronic AcidChitosanRats, Sprague-DawleyFemaleOxidative StressCell Line, TumorBlood-Spinal Cord Barrier

Stichwörter der Autor:innen

ellagic acidexosomesinjectable self‐healing hydrogelpH‐sensitivespinal cord injury

Substanzen

Ellagic AcidHydrogelsHyaluronic AcidChitosan

Autor:innen und Institutionen

  • School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Department of Pharmacy, Zhongjiang Maternal and Child Health-Care Hospital, Deyang, China.
  • Department of Orthopaedics, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • DataRevive USA LLC, Rockville, Maryland, USA.
  • West China School of Pharmacy, Sichuan University, Chengdu, China.
  • Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, China.

ORCID-Profile: Fei Lei, Zhirong Zhang

Förderung

  • Sichuan Science and Technology Program
  • Science and Technology Strategic Cooperation Program of Luzhou Municipal People's Government and Southwest Medical University
  • Open Projects Fund of the Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education

Zitieren

APA

Zhou, X., Lin, Y., Wang, R., Wu, Y., Zhong, X., Wu, J., Luo, Z., Lei, F., Liu, X., Li, X., Xu, X., Li, Y., Yang, L., Wang, C., Zhang, Z., Liu, Z., Zheng, Y., Sun, X., & Zhong, Z. (2026). Sustained Delivery of Exosome‐Encapsulated Ellagic Acid via Injectable Self‐Healing Hydrogel for Spinal Cord Injury Repair. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71750

Vancouver

Zhou X, Lin Y, Wang R, Wu Y, Zhong X, Wu J, et al. Sustained Delivery of Exosome‐Encapsulated Ellagic Acid via Injectable Self‐Healing Hydrogel for Spinal Cord Injury Repair. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71750

BibTeX
@article{Zhou2026,
  author = {Zhou, Xiaoling and Lin, Yan and Wang, Rongqiu and Wu, Yanling and Zhong, Xingyue and Wu, Jili and Luo, Zaiyi and Lei, Fei and Liu, Xingyuan and Li, Xiyao and Xu, Xueyun and Li, Yanqi and Yang, Lanlan and Wang, Changguang and Zhang, Zhirong and Liu, Zhongbing and Zheng, Youkun and Sun, Xiaoduan and Zhong, Zhirong},
  title = {Sustained Delivery of Exosome‐Encapsulated Ellagic Acid via Injectable Self‐Healing Hydrogel for Spinal Cord Injury Repair},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71750}
}
Kostenlos starten →